CRM vs DHR: Which Is the Better Buy?
Side-by-side comparison of Salesforce, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Salesforce, Inc. · Technology
$182.14
+200.4% upside to fair value
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
CRM has more upside to fair value
(+200.4%).
CRM trades at a lower forward P/E
(22.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRM |
DHR |
| Current Price |
$182.14 |
$174.04 |
| Fair Value Estimate |
$547.17 |
$197.01 |
| Upside to Fair Value |
+200.4%
|
+13.2%
|
| Market Cap |
$173.0B |
$123.2B |
| Forward P/E |
22.8x
|
33.4x
|
| EV / EBITDA |
14.4x
|
20.3x
|
| Price / Sales |
4.2x
|
5.0x
|
| Price / FCF |
12.0x
|
23.3x
|
| Revenue Growth YoY |
+12.1%
|
+3.7%
|
| Gross Margin |
77.7%
|
60.7%
|
| Operating Margin |
21.5%
|
21.0%
|
| Return on Equity |
12.4%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
8.33%
|
4.3%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Salesforce, Inc. is a leading enterprise software company specializing in cloud-based customer relationship management and enterprise applications. The company benefits from a durable competitive moat anchored by pioneering SaaS delivery, a large and growing customer base, and a diversified revenue mix with Service Cloud as the largest segment generating $9.05 billion in FY2025. Salesforce exhibi…
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
| Metric |
CRM |
DHR |
| Zone Low |
$410.38 |
$147.76 |
| Zone High |
$465.09 |
$167.46 |
| In Buy Zone? |
Yes
|
No
|